Ledger.Open graph →
SEC Form D · filed November 16, 2020

Rani Therapeutics, LLC

Offering
$75.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN JOSE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Andrew Farquharson · San Jose, CADirectorMir Hashim · San Jose, CAExec · DirectorMir Imran · San Jose, CAExec · DirectorDennis Ausiello · San Jose, CADirectorStanhope FFT Global Ventures GP-LLC · New York, NYDirectorSvai Sanford · San Jose, CAExecMaulik Nanavaty · San Jose, CADirectorRaymond L. Rozycki (Jr) · MCDONALD, PADirectorSvai Sanford · San Jose, CAExecMaulik Nanavaty · San Jose, CADirectorMir Hashim · San Jose, CAExec · DirectorMir Imran · Menlo Park, CAExec · DirectorDennis Ausiello · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗